ILV-094

ILV-094 · Wyeth (Pfizer)

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ILV-094, covering 2007-12-13 to 2024-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis [Phase 1]